These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8968655)

  • 1. Pharmacokinetics of opioids in renal dysfunction.
    Davies G; Kingswood C; Street M
    Clin Pharmacokinet; 1996 Dec; 31(6):410-22. PubMed ID: 8968655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics.
    Chan GL; Matzke GR
    Drug Intell Clin Pharm; 1987 Oct; 21(10):773-83. PubMed ID: 3322755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of opioids in liver disease.
    Tegeder I; Lötsch J; Geisslinger G
    Clin Pharmacokinet; 1999 Jul; 37(1):17-40. PubMed ID: 10451781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with opioids in liver or renal failure].
    Tegeder I; Geisslinger G; Lötsch J
    Schmerz; 1999 Jun; 13(3):183-95. PubMed ID: 12799931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
    Scholz J; Steinfath M; Schulz M
    Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opioids during anesthesia in liver and renal failure].
    Höhne C; Donaubauer B; Kaisers U
    Anaesthesist; 2004 Mar; 53(3):291-303. PubMed ID: 15074320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal impairment: a challenge for opioid treatment? The role of buprenorphine.
    Böger RH
    Palliat Med; 2006; 20 Suppl 1():s17-23. PubMed ID: 16764217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
    Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sedation and analgesia in intensive therapy].
    Pjević M; Kolak R; Komarcević M
    Med Pregl; 1998; 51(11-12):509-17. PubMed ID: 10081271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview.
    Ing Lorenzini K; Daali Y; Dayer P; Desmeules J
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):219-26. PubMed ID: 21995512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
    Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
    Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat.
    Dahlström BE; Paalzow LK; Lindberg C; Bogentoft C
    Drug Metab Dispos; 1979; 7(2):108-12. PubMed ID: 38072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry.
    Eckart K; Röhrich J; Breitmeier D; Ferner M; Laufenberg-Feldmann R; Urban R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():1-8. PubMed ID: 26241181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease.
    Murphy EJ
    Anaesth Intensive Care; 2005 Jun; 33(3):311-22. PubMed ID: 15973913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine intoxication in renal failure: the role of morphine-6-glucuronide.
    Osborne RJ; Joel SP; Slevin ML
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1548-9. PubMed ID: 3087512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of major analgesics in patients with renal dysfunction.
    Niscola P; Scaramucci L; Vischini G; Giovannini M; Ferrannini M; Massa P; Tatangelo P; Galletti M; Palumbo R
    Curr Drug Targets; 2010 Jun; 11(6):752-8. PubMed ID: 20041843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opioids in patients with renal impairment].
    Pfefferkorn F; Harings-Kaim A; Schönenberger M; Leuppi-Taegtmeyer A
    Ther Umsch; 2020; 77(1):10-13. PubMed ID: 32486992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analgesic effect of morphine and its metabolites administered by an intracerebroventricular route].
    Serrié A
    Bull Acad Natl Med; 1995 Jun; 179(6):1237-52; discussion 1252-3. PubMed ID: 8542351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.